Mammoth Biosciences

Mammoth Biosciences

Mammoth Biosciences

The world's first CRISPRenabled platform for disease detection.
Type
B2b
Founded
2017
Raised
$218M
Follow us
Featured on
Alexa global traffic share
Twitter followers
Latest funding Show all
$150,000,000
Venture capital (Series D) - 2021
Redmile Group Greenspring Associates Mayfield Fund +6
$45,000,000
Venture capital (Series B) - 2020
Mayfield Fund Decheng Capital Plum Alley +6
Team Size
1–10
Employees
TechCrunch

Build for the future now with Mammoth Biosciences and Mayfield

Reuters Top News

Bayer in gene therapy collaboration with Mammoth Biosciences

Forbes Tech

What Drives Newly Minted CRISPR Unicorn Mammoth Biosciences

$150,000,000 Venture capital (Series D)
TechCrunch , Forbes Tech , MedCity News

Breakout “CRISPR platform” company Mammoth Biosciences is officially a unicorn

Forbes Tech

Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein

TechCrunch

Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH fundings through RADx program

TechCrunch

Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test

$45,000,000 Venture capital (Series B)
FinSMEs , MedCity News

Mammoth Biosciences Raises $45M in Series B Funding Round

TechCrunch

Mammoth Biosciences aims to be Illumina for the gene editing generation

$23,000,000 Venture capital (Series A)
FinSMEs , PE HUB

CRISPR-Based Disease Detection Platform Mammoth Biosciences Raises $23M

Funding
TechCrunch

Mammoth Biosciences raises $23 million for its CRISPR-based disease detection engine

Science Funding
TechCrunch

Mammoth Biosciences launches a CRISPR-powered search engine for disease detection

Science